🔎 Trials Near Me

Hjem › KOLS › Texas › Houston

Kliniske studier for KOLS i Houston, TX

15 studier for KOLS søker deltakere på steder i og rundt Houston (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.

Offisiell studietekst (engelsk)

Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →

A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease

RekruttererFase 3
  • Research Site, Houston
  • Research Site, Houston
  • Research Site, Houston
Alder 40 til 80 · Alle kjønn · Oppdatert 2. okt. 2026 · NCT06283966

Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype

RekruttererFase 3
  • Se Houston- Site Number : 8400120, Houston
  • Aavon Clinical Trials, Llc- Site Number : 8400166, Houston
Alder 40 til 80 · Alle kjønn · Oppdatert 1. okt. 2026 · NCT07190222

A Study of Brenipatide (LY3537031) in Adult Participants With Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD)

RekruttererFase 2
  • Baylor College of Medicine Medical Center, Houston
Alder 40 til 75 · Alle kjønn · Oppdatert 25. sep. 2026 · NCT07759245

Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype

RekruttererFase 3
  • Trio Clinical Trials- Site Number : 8400106, Houston
  • HDH Research- Site Number : 8400104, Houston
  • Baylor College of Medicine- Site Number : 8400076, Houston
  • og 2 flere
Alder 40 til 80 · Alle kjønn · Oppdatert 22. sep. 2026 · NCT07190209

A Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease

RekruttererFase 2
  • Research Site, Houston
Alder 40 og eldre · Alle kjønn · Oppdatert 9. sep. 2026 · NCT07082738

Clinical Trial of Omalizumab for Allergen Sensitized and Exposed Individuals With COPD

RekruttererFase 2
  • Baylor College of Medicine, Houston
Alder 40 og eldre · Alle kjønn · Oppdatert 4. sep. 2026 · NCT07059091

A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00007)

RekruttererFase 3
  • Research Site, Houston
  • Research Site, Houston
  • Research Site, Houston
Alder 40 til 80 · Alle kjønn · Oppdatert 3. sep. 2026 · NCT06878261

A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00006)

RekruttererFase 3
  • Research Site, Houston
  • Research Site, Houston
  • Research Site, Humble · 17 mi unna
Alder 40 til 80 · Alle kjønn · Oppdatert 3. sep. 2026 · NCT06883305

A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate to Severe Chronic Obstructive Pulmonary Disease

RekruttererFase 2/3
  • Greater Heights & Memorial Pulmonary and Sleep, Houston
  • Houston Pulmonary Sleep and Allergy Associates, Houston
Alder 35 til 80 · Alle kjønn · Oppdatert 31. aug. 2026 · NCT07363694

STRIVE Post-Market Registry Study

RekruttererObservasjonsstudie
  • University of Texas Health Science Center at Houston, Houston
Alder 18 og eldre · Alle kjønn · Oppdatert 3. aug. 2026 · NCT04302272

eValuating the Efficacy and Safety of InitiatinG depemokImab earLy therApy iN Chronic Obstructive Pulmonary Disorder (COPD) With Type 2 Inflammation

RekruttererFase 3
  • GSK Investigational Site, Houston
  • GSK Investigational Site, Houston
  • GSK Investigational Site, Houston
Alder 40 til 75 · Alle kjønn · Oppdatert 28. jul. 2026 · NCT07177339

Bronchoscopic RElease of Air Trapped in Hyperinflated Emphysematous Lung - Study 3

Rekrutterer
  • Houston Methodist/Primary Critical Care, Houston
Alder 40 til 84 · Alle kjønn · Oppdatert 24. apr. 2026 · NCT06891755

Depemokimab as an Extended treatmeNt Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA-2)

RekruttererFase 3
  • GSK Investigational Site, Houston
Alder 40 til 80 · Alle kjønn · Oppdatert 9. apr. 2026 · NCT06961214

Clinical Validation of Freenome Multiomics Blood Test for Lung Cancer Screening

RekruttererObservasjonsstudie
  • Horizon Clinical Research Group, Houston
Alder 50 og eldre · Alle kjønn · Oppdatert 5. aug. 2025 · NCT06122077

myAirvo 3 (High Flow Nasal Therapy; HFNT) for COPD Patients in the Home

Rekrutterer
  • Respire Research Institute, Houston
Alder 30 og eldre · Alle kjønn · Oppdatert 6. feb. 2025 · NCT05204888

KOLS-studier i andre byer

Andre studier i Houston

Fra ClinicalTrials.gov, data hentet 4. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.